CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
70 hedge funds and large institutions have $127M invested in Concert Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
32% more funds holding
Funds holding: 53 → 70 (+17)
Holders
70
Holding in Top 10
2
Calls
$747K
Puts
$200K
Top Buyers
| 1 | +$6.99M | |
| 2 | +$5.79M | |
| 3 | +$4.21M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$3.58M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.14M |
Top Sellers
| 1 | -$141K | |
| 2 | -$80K | |
| 3 | -$56K | |
| 4 |
BlackRock
New York
|
-$52.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52K |